TinyGemsBreaks Archive - Page 23 of 123

FridayMay 10, 2024 2:30 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Reports Full Year 2023 Financial Results

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, on Thursday reported its financial results for the full year 2023, which ended on Dec. 31, 2023. Among other highlights, the company stated Fr8Fleet attained an annual revenue of $17.1 million with 48% year-over-year growth. “As we’ve discussed before, 2023 was a challenging year for many across the freight industry as participants struggled to find a balance between supply and demand after the COVID-19 pandemic…

ThursdayMay 09, 2024 11:59 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Mississippi-Based Facility Receives FTZ Status from U.S. Department of Commerce

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has been approved for Foreign Trade Zone (“FTZ”) status with the U.S. Department of Commerce for Mississippi-based commercial vehicle manufacturing and assembly center. According to the announcement, a Foreign Trade Zone is an area within the United States where foreign and domestic merchandise is generally considered to be in international commerce and outside of U.S. customs territory for duty and tariff purposes. The approval means that Mullen qualifies for a variety of benefits, including deferment of payments on duties related to import fees; the company can now match import duty payment…

WednesdayMay 08, 2024 2:12 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed); DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. According to the announcement, the second DehydraTECH study arm will use a Rybelsus(R) composition processed with DehydraTECH that is compliant with the U.S. Food and Drug Administration’s Inactive Ingredient Database…

TuesdayMay 07, 2024 2:05 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Announces Expansion Efforts, Appoints New Board Member

GEMXX (OTC: GEMZ), a leading provider of exquisite gemstone jewelry, is expanding its business model to include private equity funding for oil and gas (“O&G”) exploration. According to the announcement, the company is leveraging already-established relationships around the world as well as newly formed strategic partnerships to create a new business channel designed to fund exploration of giant (500 million barrels) and super-giant (3 billion+ barrels) oil fields located in Latin America. This strategic decision allows the company to “tap into moderate-risk, high-reward onshore O&G opportunities,” the announcement noted. GEMXX will be focused on overlooked and underexplored basins. As part…

MondayMay 06, 2024 3:23 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Launches Proprietary StudioViz(TM) End-to-End Lidar Simulator

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions for automotive and smart infrastructure applications, has unveiling StudioViz(TM), its proprietary lidar simulation platform. The powerful 3D-point cloud simulation platform is designed to expedite ADAS and AV development while also reducing implementation costs for automotive customers. StudioViz was designed by in-house Cepton software teams and features strategic functionalities such as virtual environment creation, high-fidelity lidar data visualization, placement optimization, sensor fusion assessment, perception solution development, and manufacturing validation and scaling.“StudioViz accelerates the testing, development and deployment of Cepton’s lidar technology by offering an efficient and cost-effective solution,” said Cepton product…

MondayMay 06, 2024 3:06 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid…

ThursdayMay 02, 2024 2:16 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Partners with Pritchard EV, MRSS to Target ‘Great Opportunity’ within Roadside Service MarketTinyGemsBreaks

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has partnered with Pritchard EV, a national leader in the adoption of EVs with commercial fleets and Mullen’s recently announced dealer partner, and Mobile Road Services Solution (“MRSS”), a leading upfitter for the Roadside Service Industry. The tripartite partnership is geared toward the debut of the Mullen ONE, Class 1 EV cargo van roadside assistance vehicle upfit, currently on display at the American Towman Showcase in Las Vegas, Nevada. According to the announcement, Pritchard EV worked with MRSS to identify the Mullen ONE EV cargo van as their first joint…

WednesdayMay 01, 2024 2:52 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Names New CEO, Outlines Key Components of Strategic Expansion Plans

GEMXX (OTC: GEMZ), a leading provider of exquisite gemstone jewelry, has appointed a new CEO and is expanding into proven business channels expected to deliver substantial revenue and shareholder value. According to the announcement, GEMXX founder Jay Maull has retired, and Richard Clowater has been named CEO and chair of the board. Throughout his career, Clowater has worked in upstream, midstream and downstream oil and gas projects, establishing a proven track record of leadership. According to the announcement, his strategic vision and innovative approach will be key as GEMXX moves forward in the dynamic market environment. In addition, the announcement…

WednesdayMay 01, 2024 2:34 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Q1 2024 Earnings Release, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, today announced that it will provide a business update and release its financial results for the first quarter of 2024 following the close of the market on Monday, May 13, 2024. Cepton will hold a conference call and webcast that same day at 2:30 p.m. PT (5:30 p.m. ET). Interested parties should dial 1-877-423-9813 (toll-free) or 1-201-689-8573 (international) to join the live call and visit https://investors.cepton.com to access the webcast. A telephonic replay of the conference call will be available approximately three hours after the live…

WednesdayMay 01, 2024 2:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces $4.7M Warrant Exercise Agreement

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a warrant exercise agreement with an existing accredited investor to exercise in full existing warrants. Specifically, the agreement is comprised of the purchase of 2,917,032 shares of common stock, as to 1,618,330 warrants exercised at an exercise price of $0.97 per share, and 1,298,702 warrants exercised at $2.185 per share; the shares and warrants were originally issued in October 2023 and February 2024, respectively. The company noted that following this exercise, there are no remaining warrants exercisable at $0.97 and 259,741 warrants unexercised at $2.185. According…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks